Psychiatrist Guy Goodwin joins Compass Pathways

Company
Compass Pathways Plc
Appointee name
Guy Goodwin
Country

United Kingdom

Compass Pathways Plc has appointed Guy Goodwin as chief medical officer to oversee development of psilocybin, a psychedelic prodrug for treatment-resistant depression. Professor Goodwin is Emeritus Professor of Psychiatry at The University of Oxford, UK and most recently, was medical director at P1vital Ltd, a clinical research and healthcare organisation.
Compass announced the appointment 29 July 2021.
Copyright 2021 Evernow Publishing Ltd